CSL Of Australia Loses U.S. Bid For Gardasil For Older Women
This article was originally published in PharmAsia News
Executive Summary
Australia's CSL and its Gardasil vaccine has been rejected as a U.S. FDA-approved preventative against the human papilloma virus in women over the age of 27 years